ceftriaxone + metronidazole + rifampin + moxifloxacin + placebo

This appears to be an experimental combination therapy that includes four active antibiotics (ceftriaxone, metronidazole, rifampin, and moxifloxacin) plus placebo. Ceftriaxone is a third-generation cephalosporin antibiotic with broad-spectrum activity against gram-negative bacteria. Metronidazole is an antibiotic effective against anaerobic bacteria. Rifampin is an antibiotic that inhibits bacterial RNA polymerase. Moxifloxacin is a fluoroquinolone antibiotic that disrupts bacterial DNA replication. The inclusion of placebo suggests this may be part of a clinical trial design where some components are being tested against others.